Prof. Dr. MESUT ŞEKER

Yayın Ağı

Makaleler 96

1. Real-world Efficacy and Safety of Trastuzumab Deruxtecan in HER2-positive Metastatic Breast Cancer: A Multicenter Retrospective Study from Türkiye

Muğlu H., SÜNGER E., ŞEKER CAN L., Han Ö., Güney B., HAMDARD J., et al.

Journal of Oncological Science , cilt.12, sa.1, ss.59-66, 2026 (Scopus, TRDizin)

2. Factors Affecting the Survival of Metastatic Breast Cancer Patients Treated with CDK 4/6 Inhibitors

Sucuoğlu İşleyen Z., MUĞLU H., Alaca Topçu Z., Beşiroğlu M., Yasin A. İ., Topçu A., et al.

Medicina (Lithuania) , cilt.61, sa.7, 2025 (SCI-Expanded, Scopus)

3. Characteristic features and prognostic factors in gastric cancer patients with bone metastases: multicenter experience

HAMDARD J., BİLİCİ A., Sakin A., Kahraman S., YASİN A. İ., KALACI E., et al.

JOURNAL OF CHEMOTHERAPY , cilt.37, sa.3, ss.268-277, 2025 (SCI-Expanded, Scopus)

4. Cardiac safety of ribociclib evaluated with 24-hour rhythm Holter electrocardiogram

Yasin A. I., ULUGANYAN M., Isleyen Z. S., Topcu A., Shbair A. T., ŞİMŞEK M., et al.

Supportive Care in Cancer , cilt.32, sa.8, 2024 (SCI-Expanded, Scopus)

5. Is Clinical Risk Score a Useful Predictive Marker of Early Recurrence Among Metastatic Breast Cancer Patients Treated with CDK4/6 Inhibitors?

OVEN B. B., ÖKTEN I. N., BİLİCİ A., YASİN A. I., KOCA S., YÜZÜGÜLLÜ E., et al.

Eurasian Journal of Medical Investigation , cilt.8, sa.2, ss.106-112, 2024 (TRDizin)

6. Pretreatment HALP Score Predicts Prognosis in Patients with Esophageal Cancer Treated with Chemoradiotherapy

İŞLEYEN Z. S., BEŞİROĞLU M., ŞİMŞEK M., YASİN A. İ., TOPÇU A., AKÇAKAYA A., et al.

Eurasian Journal of Medical Investigation , cilt.8, sa.2, ss.113-118, 2024 (TRDizin)

7. Prognostic significance of HER2 loss after HER2-targeted neoadjuvant treatment in patients with HER2-positive locally advanced breast cancer

KUTLU Y., Cekin R., AYDIN S., Shbair A. T. M., BİLİCİ A., Arici S., et al.

Current Problems in Cancer , cilt.50, 2024 (SCI-Expanded, Scopus)

8. Local interventions for colorectal cancer metastases to liver and lung

ŞİMŞEK M., Besiroglu M., AKÇAKAYA A., Topcu A., Yasin A. I., Isleyen Z. S., et al.

Irish Journal of Medical Science , cilt.192, sa.6, ss.2635-2641, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

9. Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study

AYDIN S., Kavak E. E., Topcu A., BAYRAMGİL A., Akgul F., Kahraman S., et al.

Biomolecules and Biomedicine , cilt.23, sa.6, ss.1089-1095, 2023 (SCI-Expanded, Scopus)

10. The prognostic value of tumor budding in gastric adenocarcinomas: A cross-sectional study

Baydas T., ÇOBAN G., Besiroglu M., ŞİMŞEK M., Shbair A. T., Topcu A., et al.

International Journal of Gastrointestinal Intervention , cilt.12, sa.2, ss.69-74, 2023 (ESCI, Scopus) Sürdürülebilir Kalkınma

11. The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer

ŞİMŞEK M., Yasin A., BEŞİROĞLU M., TOPÇU A., SUCUOĞLU İŞLEYEN Z., ŞEKER M., et al.

JOURNAL OF MEDICAL VIROLOGY , cilt.94, sa.9, ss.4138-4143, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

12. Real-life analysis of pathologic complete response with neoadjuvant trastuzumab plus taxane with or without pertuzumab therapy in HER2 positive locally-advanced breast cancer (HER2PATH Study).

Bilici A., Olmez O. F., Sezer A., Oksuzoglu B., Kaplan M. A., Karadurmus N., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.40, sa.16, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

13. Efficacy and safety profile of COVID-19 vaccine in cancer patients: a prospective, multicenter cohort study

YASİN A. İ., Aydin S. G., SÜMBÜL B., KORAL L., ŞİMŞEK M., Geredeli C., et al.

FUTURE ONCOLOGY , cilt.18, ss.1235-1244, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

14. The Impact of Hybrid Capture-Based Comprehensive Genomic Profiling on Treatment Strategies in Patients with Solid Tumors

Dişel U., Köse F., Bilici A., ÖZGÜROĞLU M., Sağlam S., ŞEKER M., et al.

Journal of Oncological Science , cilt.8, sa.2, ss.87-93, 2022 (Scopus, TRDizin)

15. Real-life analysis of treatment approaches and the role of inflammatory markers on survival in patients with advanced biliary tract cancer

Goktas Aydin S., Cakan Demirel B., Bilici A., TOPÇU A., Aykan M. B., KAHRAMAN S., et al.

Current Medical Research and Opinion , cilt.38, sa.10, ss.1751-1758, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

16. A case report of fulminant hepatitis due to ribociclib with confirmed by liver biopsy in breast cancer

TOPÇU A., YASİN A. İ., SHBAIR A. T., BEŞİROĞLU M., ŞİMŞEK M., SUCUOĞLU İŞLEYEN Z., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.28, sa.1, ss.242-246, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

17. Platelet to lymphocyte ratio is associated with tumor localization and outcomes in metastatic colorectal cancer

Acikgoz O., Cakan B., DEMİR T., Bilici A., Oven B. B., Hamdard J., et al.

MEDICINE , cilt.100, sa.44, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

18. Primitive Neuroectodermal Tumor of the Testis

DEMİR T., ALİYEV A., ŞEKER M., ERSÖZ C., ÇOBAN G., TÜRK H. M.

JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN , cilt.31, sa.11, ss.1362-1365, 2021 (SCI-Expanded, Scopus)

19. Evaluation of Kidney Function in Patients on Chemotherapy

Haziyev E., GÜRSU M., ŞEKER M., ELÇİOĞLU Ö. C., ARTAN A. S., ALİYEV A., et al.

TURKISH JOURNAL OF NEPHROLOGY , cilt.30, sa.2, ss.138-144, 2021 (ESCI, Scopus, TRDizin)

20. Clinicopathological features of gastroenteropancreatic neuroendocrine neoplasms: a retrospective single-center experience

ŞEKERCİ A., TÜRK H. M., DEMİR T., ŞEKER M., AKÇAKAYA A., ARICI D. S.

NEUROENDOCRINOLOGY , cilt.111, ss.20, 2021 (SCI-Expanded, Scopus)

21. Determine the impact of hybrid capture-based comprehensive genomic profiling (CGP) on the treatment strategies in patients with solid tumors: A national, multicenter, retrospective study.

Disel U., Kose F., Bilici A., Ozguroglu M., Saglam S., Seker M., et al.

JOURNAL OF CLINICAL ONCOLOGY , cilt.38, sa.15, 2020 (SCI-Expanded, Scopus)

22. Usefulness of serum M30 and M65 levels to predict response to neoadjuvant chemotherapy in patients with breast cancer.

Turk H. M., Aliyev A., Celik R., Seker M., Coban E., Demir T., et al.

Current problems in cancer , cilt.44, sa.1, ss.100497, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

23. Correlationof Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy.

ŞEKER M., AYDIN D., BİLİCİ A., YAVUZER D., GEÇER M., ÖZÇELİK M., et al.

Oncology Research , 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

24. Prognostic Factors for Operated Gallbladder Cancer.

Oven U., Bilici A., Seker M., Kefeli U., Aydin D., Celik S., et al.

Journal of gastrointestinal cancer , cilt.50, ss.451-457, 2019 (ESCI, Scopus) Sürdürülebilir Kalkınma

25. Prognostic Impact of Primary Tumor Location on Survival in Metastatic Colorectal Cancer Patients: A single center experience

DEMİR T., ARAZ M., ÇOBAN E., ALİYEV A., ŞEKER M., TÜRK H. M.

Medicine Science , cilt.8, sa.3, ss.500-502, 2019 (TRDizin) Sürdürülebilir Kalkınma

26. Prognostic Significance of Metastatic Lymph Node Ratio in Patients with pN3 Gastric Cancer Who Underwent Curative Gastrectomy.

Bilici A., Selcukbiricik F., Seker M., Oven B., Olmez O., Yildiz O., et al.

Oncology research and treatment , cilt.42, ss.209-216, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

27. Cutaneous Involvement of Lung Adenocarcinom

Cengiz F. P., Tosuner Z., Sonmez B., Seker M., Emiroglu N., Turk H. M., et al.

BEZMIALEM SCIENCE , cilt.6, sa.4, ss.329-330, 2018 (ESCI, TRDizin)

28. Role of Urotensin-2 in 5-Fluorouracil-Related Arterial Vasoconstriction in Cancer Patients

Seker M., ISEN H. C., Cevirme N., Aydin S., Bilici A., Bulut H., et al.

ONCOLOGY RESEARCH AND TREATMENT , cilt.41, sa.9, ss.545-549, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

29. Scalp recurrence of cholangiocarcinoma after curative hepatectomy: A report of two cases

Kunduz E., Serin K. R., Şeker M.

MOLECULAR AND CLINICAL ONCOLOGY , cilt.7, sa.6, ss.1122-1124, 2017 (ESCI, Scopus)

30. Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy

Seker M., AYDIN D., Bilici A., YAVUZER D., OZGUN M., OZCELIK M., et al.

ONCOLOGY RESEARCH AND TREATMENT , sa.4, ss.185-190, 2017 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Comparison of efficacy and safety of three different chemotherapy regimens delivered with concomitant radiotherapy in inoperable stage III non-small cell lung cancer patients

OZCELIK M., KORKMAZ T., ODABAS H., GEMICI C., ERCELEP O., YUKSEL S., et al.

TUMOR BIOLOGY , cilt.37, sa.7, ss.8901-8907, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

32. Evaluation of prognostic factors in localized high-grade undifferentiated pleomorphic sarcoma: report of a multi-institutional experience of Anatolian Society of Medical Oncology

OZCELIK M., ŞEKER M., ERASLAN E., Koca S., YAZILITAS D., ERCELEP O., et al.

Tumor Biology , cilt.37, sa.4, ss.5231-5237, 2016 (SCI-Expanded, Scopus)

33. Pretreatment PET/ct standardized uptake values play a role in predicting response to treatment and survival in patients with small cell lung cancer

DINC N. S., AYDLN K., ODABAS H., ERCELEP O., Tufan G., ŞEKER M., et al.

Oncology Research and Treatment , cilt.39, sa.3, ss.130-134, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. The changing of serum vitamin B12 and homocysteine levels after gastrectomy in patients with gastric cancer: do they associate with clinicopathological factors?

BILICI A., SONKAYA A., ERCAN S., USTAALIOĞLU B., Seker M., ALIUSTAOGLU M., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.36, ss.823-8, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

35. Clinical and pathologic features of patients with rare ovarian tumors: multi-center review of 167 patients by the anatolian society of medical oncology.

BILICI A., INANC M., ULAS A., AKMAN T., Seker M., BABACAN N., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.14, ss.6493-9, 2014 (SCI-Expanded, Scopus)

36. Important factors affecting adjuvant treatment decision in stage IA breast cancer patients in Turkey

OVEN USTAALIOGLU B. B., Bilici A., YILMAZ B. E., ALIUSTAOGLU M., Seker M., VARDAR F., et al.

Breast Care , cilt.9, sa.2, ss.123-127, 2014 (SCI-Expanded, Scopus)

37. Treatment modalities in primary gastric lymphoma: The effect of rituximab and surgical treatment. A study by the Anatolian Society of Medical Oncology

Mehmet K., SENER C., UYETURK U., Seker M., Tastekin D., Tonyali O., et al.

Wspolczesna Onkologia , cilt.18, sa.4, ss.273-278, 2014 (SCI-Expanded, Scopus)

38. Efficacy of sunitinib in Turkish patients with gastrointestinal stromal tumors; retrospective multicenter experience.

KEFELI U., BUYUBERBER S., AKYOL M., YILDIZ R., KAPLAN M., CILTAS A., et al.

Hepato-gastroenterology , cilt.60, ss.647-52, 2013 (SCI-Expanded, Scopus)

39. The prognostic importance of changing serum M30 and M65 values after chemotherapy in patients with advanced-stage non-small-cell lung cancer.

USTAALIOĞLU B., BILICI A., ERCAN S., Seker M., ORCUN A., GUMUS M.

Medical oncology (Northwood, London, England) , cilt.30, ss.551, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

40. Prognostic factors in gastrointestinal stromal tumors: multicenter experience of 333 cases from Turkey.

Seker M., SEVINC A., YILDIZ R., CIHAN S., KAPLAN M., GOKDURNALI A., et al.

Hepato-gastroenterology , cilt.60, ss.768-75, 2013 (SCI-Expanded, Scopus)

41. Childhood, adolescents, and young adults (≤25 y) colorectal cancer: study of Anatolian Society of Medical Oncology.

KAPLAN M., ISIKDOGAN A., GUMUS M., ARSLAN U., GEREDELI C., OZDEMIR N., et al.

Journal of pediatric hematology/oncology , cilt.35, ss.83-9, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

42. XELIRI plus bevacizumab compared with FOLFIRI plus bevacizumab as first-line setting in patients with metastatic colorectal cancer: experiences at two-institutions.

UYGUN K., BILICI A., KAYA S., Oven U., YILDIZ R., TEMIZ S., et al.

Asian Pacific journal of cancer prevention : APJCP , cilt.14, ss.2283-8, 2013 (SCI-Expanded, Scopus)

43. The prognostic significance of the increase in the serum M30 and M65 values after chemotherapy and relationship between these values and clinicopathological factors in patients with advanced gastric cancer.

BILICI A., USTAALIOĞLU B., ERCAN S., Seker M., YILMAZ B., ORCUN A., et al.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine , cilt.33, ss.2201-8, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

44. Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients.

ELKIRAN E., KAPLAN M., SEVINC A., AKSOY S., DEMIRCI U., Seker M., et al.

Medical oncology (Northwood, London, England) , cilt.29, ss.3147-54, 2012 (SCI-Expanded, Scopus)

45. The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.

USTAALIOGLU B., BILICI A., KEFELI U., Şeker M., ONCEL M., GEZEN C., et al.

American journal of clinical oncology , cilt.35, ss.580-6, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

46. The prevalence and significance of autoantibodies in patients with non-Hodgkin's lymphoma: are they correlated with clinicopathological features?

BILICI A., YAPICI H., ERCAN S., Seker M., USTAALIOĞLU B., SALMAN T., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.17, ss.502-7, 2012 (SCI-Expanded, Scopus)

47. Prognostic significance of high phosphatase of regenerating liver-3 expression in patients with gastric cancer who underwent curative gastrectomy.

BILICI A., USTAALIOĞLU B., YAVUZER D., Seker M., MAYADAGLI A., GUMUS M.

Digestive diseases and sciences , cilt.57, ss.1568-75, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. Serum M30 and M65 values in patients with advanced stage non-small-cell lung cancer compared with controls.

Oven U., BILICI A., ERCAN S., ORCUN A., Seker M., OZKAN A., et al.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico , cilt.14, ss.356-61, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

49. Is subdivision of pT2 tumors superior to lymph node metastasis for predicting survival of patients with gastric cancer? Review of 224 patients from four centers.

BILICI A., DANE F., Seker M., USTAALIOĞLU B., ALIUSTAOGLU M., TEMIZ S., et al.

Digestive diseases and sciences , cilt.56, ss.3226-34, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

50. Tissue and Serum Adiponectin Levels in Patients with Gastric Cancer: Are there any Correlations between Adiponectin Levels and Histopathological Variables?

ŞEKER M., Bilici A., Güler D. Ö., Ustaalioglu B. B., Gozu H., Erkal F. Y., et al.

HEPATO-GASTROENTEROLOGY , cilt.58, sa.110, ss.1841-1846, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Prognostic factors in elderly patients with non-small cell lung cancer: a two-center experience.

KEFELI U., KAYA S., USTAALIOGLU B., BILICI A., KEFELI A., YILDIRIM M. Ş., et al.

Medical oncology (Northwood, London, England) , cilt.28, ss.661-6, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

52. Is there any impact of plasma M30 and M65 levels on progression-free survival of patients with advanced gastric cancer?

BILICI A., USTAALIOĞLU B., ERCAN S., ORCUN A., Seker M., SALEPCI T., et al.

Cancer chemotherapy and pharmacology , cilt.68, ss.309-16, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

53. Clinicopathologic features of the nine patients with primary diffuse large B cell lymphoma of the breast

ŞEKER M., Bilici A., Ustaalioglu B. Ö., Yılmaz B., Öztürk B., Ünal A., et al.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS , cilt.284, sa.2, ss.405-409, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

54. F-18 FDG PET/CT imaging and bronchoscopic image of tracheal recurrence in patient with non-small-cell lung cancer.

Oven U., KEFELI U., BILICI A., USTAALIOGLU R., Seker M., CINARAL F., et al.

Clinical nuclear medicine , cilt.36, ss.367-9, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Co-existence of gastrointestinal stromal tumors with other primary neoplasms.

SEVINC A., Seker M., BILICI A., OZDEMIR N., YILDIZ R., USTAALIOGLU B., et al.

Hepato-gastroenterology , cilt.58, ss.824-30, 2011 (SCI-Expanded, Scopus)

56. Pulmonary BALT lymphoma successfully treated with eight cycles weekly rituximab: Report of first case and F-18 FDG PET/CT images

Bilici A., Seker M., USTAALIOGLU B. B. O., CANPOLAT N., Salepci T., Gümüş M.

Journal of Korean Medical Science , cilt.26, sa.4, ss.574-576, 2011 (SCI-Expanded, Scopus)

57. A retrospective analysis of women's chances to become pregnant after completion of chemotherapy: a single center experience

USTAALIOGLU B. B. O., BILICI A., KEFELI U., Seker M., SALEPCI T., UNAL O., et al.

JOURNAL OF BUON , cilt.16, sa.2, ss.349-352, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

58. Is there any correlation among adiponectin levels in serum, tumor tissue and normal tissue of the same patients wih breast cancer?

SONMEZ B., Seker M., BILICI A., Yavuz E., Oven U., GUMUS M., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.16, ss.227-32, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. The role of PET-CT in the differential diagnosis of thymic mass after treatment of patients with lymphoma.

USTAALIOĞLU B., Seker M., BILICI A., CANPOLAT N., YILDIRIM E. Ö., KEFELI U., et al.

Medical oncology (Northwood, London, England) , cilt.28, ss.258-64, 2011 (SCI-Expanded, Scopus)

60. A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy.

KEFELI U., BILICI A., USTAALIOĞLU B., KEFELI A., YILDIRIM M. Ş., Seker M., et al.

Archives of gynecology and obstetrics , cilt.283, ss.405-7, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Primary breast mantle cell lymphoma with atypical relapse patterns.

DANE F., Seker M., Fulden Y., GUNDUZ F., PEKER O., BASARAN G., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.16, ss.181-2, 2011 (SCI-Expanded, Scopus)

62. The role of ¹⁸F-FDG PET/CT in the assessment of suspected recurrent gastric cancer after initial surgical resection: can the results of FDG PET/CT influence patients' treatment decision making?

BILICI A., USTAALIOĞLU B., Seker M., KEFELI U., CANPOLAT N., TEKINSOY B., et al.

European journal of nuclear medicine and molecular imaging , cilt.38, ss.64-73, 2011 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

63. The effect of peripheral blood values on prognosis of patients with locally advanced gastric cancer before treatment.

ALIUSTAOGLU M., BILICI A., USTAALIOĞLU B., KONYA V., GUCUN M., Seker M., et al.

Medical oncology (Northwood, London, England) , cilt.27, ss.1060-5, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

64. The association of serum adiponectin levels with histopathological variables in gastric cancer patients

ŞEKER M., Bilici A., Sönmez B., Ustaalioglu B. B., Gümüş M., Gozu H., et al.

MEDICAL ONCOLOGY , cilt.27, sa.4, ss.1319-1323, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

65. Neoadjuvant chemotherapy followed by interval cytoreductive surgery in patients with unresectable, advanced stage epithelial ovarian cancer: a single centre experience.

BILICI A., SALEPCI T., DANE F., GUMUS M., USTAALIOĞLU B., Seker M., et al.

Archives of gynecology and obstetrics , cilt.282, ss.417-25, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

66. Determining of metastatic lymph node ratio in patients who underwent D2 dissection for gastric cancer.

BILICI A., Seker M., USTAALIOĞLU B., YILMAZ B., DOVENTAS A., SALEPCI T., et al.

Medical oncology (Northwood, London, England) , cilt.27, ss.975-84, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

67. Case report: soft tissue metastasis from immature teratoma of the testis: second case report and review of the literature.

BILICI A., USTAALIOĞLU B., Seker M., KAYAHAN S.

Clinical orthopaedics and related research , cilt.468, ss.2541-4, 2010 (SCI-Expanded, Scopus)

68. Prognostic significance of perineural invasion in patients with gastric cancer who underwent curative resection.

BILICI A., Seker M., USTAALIOĞLU B., KEFELI U., YILDIRIM E. Ö., YAVUZER D., et al.

Annals of surgical oncology , cilt.17, ss.2037-44, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

69. Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences.

Anatolian M., USTAALIOĞLU B., GUMUS M., UNAL A. S., CAYIR K., SEVER O., et al.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society , cilt.20, ss.698-703, 2010 (SCI-Expanded, Scopus)

70. Clinical value of FDG PET/CT in the diagnosis of suspected recurrent ovarian cancer: is there an impact of FDG PET/CT on patient management?

BILICI A., USTAALIOĞLU B., Seker M., CANPOLAT N., TEKINSOY B., SALEPCI T., et al.

European journal of nuclear medicine and molecular imaging , cilt.37, ss.1259-69, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

71. Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma.

Seker M., USTAALIOĞLU B., BILICI A., YILDIRIM M. Ş., KEFELI U., BARISIK N., et al.

Leukemia research , cilt.34, 2010 (SCI-Expanded, Scopus)

72. Is there a cut-off value for standardized uptake values in positron emission tomography for predicting response to treatment and survival in patients with advanced non-small cell lung cancer? Single center experience.

Oven U., GUMUS M., BILICI A., Seker M., USTAALIOGLU R., KEFELI U., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.15, ss.529-36, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

73. Preoperative serum leptin levels in patients with breast cancer.

ALIUSTAOGLU M., BILICI A., GUMUS M., COLAK A., BALOGLU G., IRMAK R., et al.

Medical oncology (Northwood, London, England) , cilt.27, ss.388-91, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

74. Neoadjuvant chemotherapy for locally advanced breast cancer: a single center experience.

USTAALIOĞLU B., GUMUS M., BILICI A., Seker M., DANE F., SALEPCI T., et al.

Medical oncology (Northwood, London, England) , cilt.27, ss.454-8, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

75. The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer.

ALIUSTAOGLU M., BILICI A., Seker M., DANE F., GOCUN M., KONYA V., et al.

Hepato-gastroenterology , cilt.57, ss.640-5, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

76. Primary non-Hodgkin lymphoma of cervix successfully treated with rituximab: positron emission tomography images before and after therapy: a case report.

USTAALIOĞLU B., BILICI A., Seker M., CANPOLAT N., OZDEMIR N., SALEPCI T., et al.

Leukemia research , cilt.34, 2010 (SCI-Expanded, Scopus)

77. F-18 FDG PET/CT imaging in recurrent mantle cell lymphoma presenting with cauda equina syndrome.

BILICI A., USTAALIOĞLU B., Seker M., CANPOLAT N., GUMUS M.

Clinical nuclear medicine , cilt.35, ss.211-2, 2010 (SCI-Expanded, Scopus)

78. Does the metastatic lymph node ratio influence the disease-free survival of patients with breast cancer: single-center experiences.

Oven U., BILICI A., KEFELI U., Seker M., YILDIRIM E. Ö., SALEPCI T., et al.

Oncology , cilt.79, ss.105-11, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

79. Bilateral conjunctival MALT lymphoma mimicking chronic conjunctivitis.

Seker M., OZDEMIR B., BILICI A., USTAALIOĞLU B., SONMEZ B., YILMAZ B., et al.

Onkologie , cilt.33, ss.317-20, 2010 (SCI-Expanded, Scopus)

80. The effect of tumor size on overall survival in patients with pT3 gastric cancer: experiences from 3 centers.

BILICI A., UYGUN K., Seker M., USTAALIOĞLU B., ALIUSTAOGLU M., TEMIZ S., et al.

Onkologie , cilt.33, ss.676-82, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

81. Lung cancer presenting with extreme leukocytosis.

SALMAN T., Seker M., BILICI A., Basak-Oven U., GUMUS M., YAYLACI M.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.15, ss.193, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

82. Is metastatic lymph node ratio superior to the number of metastatic lymph nodes to assess outcome and survival of gastric cancer?

BILICI A., USTAALIOĞLU B., GUMUS M., Seker M., YILMAZ B., KEFELI U., et al.

Onkologie , cilt.33, ss.101-5, 2010 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

83. Factors that Affect Patients' Decision-Making about Mastectomy or Breast Conserving Surgery, and the Psychological Effect of this Choice on Breast Cancer Patients.

GUMUS M., USTAALIOGLU B., GARIP M., KIZILTAN E., BILICI A., Seker M., et al.

Breast care (Basel, Switzerland) , cilt.5, ss.164-168, 2010 (SCI-Expanded, Scopus)

84. Bilateral primary small lymphocytic lymphoma of the lacrimal sac and review of the literature.

USTAALIOĞLU B., BILICI A., Seker M., GUMUS M., OZDEMIR N., SALMAN T., et al.

Leukemia research , cilt.33, 2009 (SCI-Expanded, Scopus)

85. Acute renal failure and multiple extranodal involvement in a patient with diffuse large B cell lymphoma.

Seker M., USTAALIOĞLU B., BILICI A., OZSEKER N., AKSU A., GUMUS M.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.14, ss.726-7, 2009 (SCI-Expanded, Scopus)

86. Renal cell carcinoma with pulmonary metastasis misdiagnosed as other primary malignant tumor.

Ustaalioglu O., BILICI A., Seker M., SALEPCI T., KESER S., GUMUS M.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.14, ss.727-8, 2009 (SCI-Expanded, Scopus)

87. Myasthenia gravis and autoimmune Addison disease in a patient with thymoma.

Seker M., GOZU H., Oven U., SONMEZ B., ERKAL F., KOCAK M., et al.

Clinical lung cancer , cilt.10, ss.367-70, 2009 (SCI-Expanded, Scopus)

88. Extended rituximab schedules may result in increased efficacy in pulmonary malt lymphoma.

Seker M., BILICI A., USTAALIOGLU B., SALMAN T., SONMEZ B., CANPOLAT N., et al.

Leukemia research , cilt.33, 2009 (SCI-Expanded, Scopus)

89. Metastatic renal hemangiopericytoma: A rare case report

Bilici A., Ustaalioglu B. B. O., Seker M., Salman T., Igdem A. A., Celik E., et al.

Archive of Oncology , cilt.17, ss.32-35, 2009 (Scopus)

90. Detection of human papillomavirus DNA by polymerase chain reaction and southern blot hybridization in colorectal cancer patients.

SALEPCI T., YAZICI H., DANE F., TOPUZ E., DALAY N., ONAT H., et al.

Journal of B.U.ON. : official journal of the Balkan Union of Oncology , cilt.14, ss.495-9, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

91. Metastasis of lobular breast carcinoma to the uterus in a patient under anastrozole therapy.

USTAALIOĞLU B., BILICI A., Seker M., SALMAN T., GUMUS M., BARISIK N., et al.

Onkologie , cilt.32, ss.424-6, 2009 (SCI-Expanded, Scopus)

92. Induction Chemotherapy and Chemoradiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer: A Single-Institution Review of Two Different Regimens

KOCAK M., OZKAN A., Mayadagli A., PARLAK C., Bilici A., Seker M., et al.

CLINICAL LUNG CANCER , cilt.10, sa.2, ss.124-129, 2009 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

93. Gastric pneumatosis intestinalis associated with malignancy: an unusual case report.

BILICI A., KARADAG B., DOVENTAS A., Seker M.

World journal of gastroenterology , cilt.15, ss.758-60, 2009 (SCI-Expanded, Scopus)

94. Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer.

KOLDAS M., GUMMUS M., Seker M., SEVAL H., HULYA K., DANE F., et al.

Clinical lung cancer , cilt.9, ss.112-5, 2008 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

95. Is adiponectin level a predictor of nonalcoholic fatty liver disease in nondiabetic male patients?

SARGIN H., SARGIN M., GOZU H., ORCUN A., BALOGLU G., OZISIK M., et al.

World journal of gastroenterology , cilt.11, ss.5874-7, 2005 (SCI-Expanded, Scopus)

96. The evaluation of left ventricular hypertrophy in hypertensive patients with subclinical hyperthyroidism.

TAMER I., SARGIN M., SARGIN H., Seker M., BABALIK E., TEKCE M., et al.

Endocrine journal , cilt.52, ss.421-5, 2005 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 6

Metrikler

Yayın

103

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

1015

H-İndeks (WoS)

Atıf (Scopus)

1134

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler